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Abstract
This article presents the proceedings of a symposium presented at the meeting of the International
Society for the Biomedical Research on Alcoholism (ISBRA), held in Manheim, Germany, in
September 2004. The organizers and chairpersons were Subhash C. Pandey and Toshikazu Saito.
The presentations were (1) Ethanol and NMDA receptor coupling to ERK signaling, by L.J. Chandler;
(2) Ethanol modulation of CREB: Role in neurogenesis, by Fulton Crews;(3) Serotonin dysfunction
and alcohol preference in mice deficient in brain-derived neurotrophic factor (BDNF), by Julie G.
Hensler; (4) BDNF gene and related signaling: role in anxiety and alcohol dependence and
preference, by Subhash C. Pandey; (5) BDNF and CREB: role in ethanol induced neuronal damage,
Wataru Ukai.
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INTRODUCTION
ALCOHOL DEPENDENCE IS a complex disease and may involve adaptations in several neurotransmitters
and neuromodulator systems in brain circuitry (Eckardt et al., 1998; Koob, 2003). Brain derived
neurotrophic factor (BDNF) is a member of the nerve growth factor family of neurotrophic
factors, which includes nerve growth factor, Neurotrophin-3, Neurotrophin-4/5 and BDNF
(Thoenen, 1995; Poo, 2001; Lu, 2003). The neurotrophic factors play a critical role in the
guidance and development of neuronal systems as well as being important in the survival,
differentiation and function of neurons (Finkbeiner et al., 1997; Huang and Reichardt,
2001;Gorski et al., 2003). The action of BDNF is mediated by binding to tyrosine kinase B
(Trk B) receptors and subsequently activation of the mitogen activated protein (MAP) kinase
[also known as extracellular signal-regulated kinases 1/2 (ERK1/2)] signal transduction
pathway (Chao, 2003; Pandey, 2004). Other kinases such as calcium calmodulin-dependent
protein kinases and cAMP dependent protein kinase A also activate cyclic AMP responsive
element binding (CREB) protein by phosphorylation at serine-133 (Silva et al.,1998; Soderling,
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1999; Pandey, 2004). BDNF is a cyclic AMP inducible gene and is regulated by the CREB
gene transcription factor. Thus, CREB serves as both an up and downstream molecular target
for the action of BDNF in the brain (Shieh et al., 1998; Chao, 2003).
The role of BDNF has been implicated in several neurological and psychiatric conditions such
as synaptic plasticity associated with learning and memory, depression and stress (Poo,
2001; Lu, 2003; Nestler et al., 2002; Duman et al., 2000). Using various approaches during
recent years, several investigators have pointed out that BDNF gene and its signaling (ERK1/2
and CREB) play a crucial role in alcohol dependence; preference and ethanol induced brain
damage. This symposium provided an attractive forum to highlight the current developments
in the role of BDNF and related signaling in the action of ethanol.
ETHANOL AND NMDA RECEPTOR COUPLING TO ERK SIGNALING
L.J. Chandler
NMDA receptors regulate neuronal development, and neuronal survival and death (Collingride
and Lester, 1989). Accumulating evidence also indicates they are important sites of action of
ethanol in both the adult and developing brain. Acutely, ethanol attenuates NMDA receptor
activity, and this inhibitory effect may contribute to its intoxicating actions (Chandler et al.,
1998). Alterations in NMDA receptor function by ethanol have been implicated in brain
plasticity, including the plasticity of addiction (Chandler, 2003).
The ERK cascade is a prototypical growth factor signaling pathway that regulates neuronal
plasticity and survival (Sweatt, 2001). In addition, it is now clear that calcium-mobilizing
receptors, including NMDA receptors, modulate neuronal function through ERK signaling
events (Chandler, 2003). Interestingly, Dr. Chandler and his group have previously
demonstrated that NMDA receptor coupling to ERK signaling is bidirectional. This
bidirectionality is characterized by NMDA receptor coupling to opposing stimulatory and
inhibitory pathways (Chandler et al., 2001). Based upon similar studies demonstrating that
extrasynaptic NMDA receptors couple to a dominant inhibitory pathway that shuts-off CREB
activation coupled to synaptic NMDA receptors, they hypothesized a similar spatial separation
for NMDA receptor coupling to ERK signaling. As an initial test of this hypothesis, Dr.
Chandler and his group utilized the MK-801 trapping technique to selectively block synaptic
receptors while leaving extrasynaptic receptors unblocked. Following MK-801 block of
synaptic receptors in primary cortical cultures, addition of NMDA resulted in a rapid reduction
in basal (activity-dependent) phospho-ERK. These observations are consistent with their
hypothesis that extrasynaptic NMDA receptors stimulate a dominant ERK shut-off pathway
of synaptic activation of ERK signaling. However, it should be noted that these results do not
indicate that the shut-off pathway is selectively coupled with extrasynaptic NMDA receptors
as synaptic NMDA receptors could also couple to an inhibitory pathway. However, previous
observations by this group and others that only ERK activation is associated with NMDA
receptors regardless of how hard synaptic activity is driven, would argue against an inhibitory
action of synaptic NMDA receptors (Chandler, 2003).
A number of recent studies have also implicated BDNF in the actions of ethanol in brain
(Climent et al., 2002; McGough et al., 2004). Since a primary signaling pathway utilized by
BDNF is the ERK signaling cascade, they next addressed the question of whether the NMDA
receptor shut-off pathway, which exerts dominant control over the synaptic NMDA receptor
activation pathway, exerts similar dominant inhibition of BDNF activation of ERK signaling.
For these experiments, synaptic NMDA receptors were first selectively blocked with MK-801
that was followed by 1hr incubation with TTX to eliminate basal levels of phospho-ERK.
Following this, BDNF was added with or without simultaneous addition of NMDA. In a
separate set of experiments, addition of BDNF was delayed 10 min after the addition of NMDA.
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Immunoblot analysis of phospho-ERK levels revealed that while BDNF produced a rapid
increase in phospho-ERK levels, in neither instance did NMDA attenuate this increase.
The results of these experiments suggest that NMDA receptor-coupled ERK modulatory
pathways are compartmentalized with spatially distinct populations of NMDA receptors.
Furthermore, while NMDA receptor signaling plays an important role in transcriptional
regulation of BDNF expression, NMDA and BDNF coupling to ERK activation functions
independently (Chandler, 2003). Dr. Chandler and his group have also recently observed that
prolonged ethanol exposure of cultured neurons leads to a selective increase in synaptic NMDA
receptors without altering extrasynaptic receptors. This effect occurs through activity-
dependent homeostatic processes that restore stability to the neuronal network in response to
the inhibitory effects of ethanol. They propose a molecular model in which chronic ethanol-
induced increases in synaptic NMDA receptors enhance BDNF expression (via enhanced
NMDA receptor-ERK-CREB signaling) without directly altering BDNF activation of ERKs
(Chandler, 2003).
ETHANOL MODULATION OF CREB: ROLE IN NEUROGENESIS
Fulton Crews and Kim Nixon
Genes induced by activated CREB play a critical role in many process such as neuronal
plasticity, long term memory (Lonze and Ginty, 2002; Silva et al., 1998), drug addiction
(Nestler, 2002) and the promotion of neuronal cell survival through regulating the transcription
of pro-survival factors (Dawson and Ginty, 2002; Lonze and Ginty, 2002; Riccio et al.,
1999). CREB also promotes neurogenesis by contributing to proliferation, differentiation and
survival of newborn neuronal cells. New born immature neurons are CREB positive in mouse
and rat dentate gyrus (Nakagawa et al., 2002a; 2002b). Adult neurogenesis (the formation of
new neurons) has recently been discovered as a form of neural plasticity that contributes to
memory, learning and mood (Crews et al., 2003; Eisch, 2002). Thus, phosphorylated CREB
(p-CREB) and the associated transcriptional activation by p-CREB underlie brain neural
plasticity, growth and vitality through activation of neuronal growth and survival processes
and increased neurogenesis.
Ethanol (alcohol) is known to alter a variety of signaling pathways, particularly receptor
operated ion channels such as the NMDA-glutamate receptor and G protein receptors coupled
to adenylate cyclase (Chandler et al., 1998; Crews et al., 1996). These signaling pathways
produce complex effects on CREB phosphorylation depending upon the brain region, kinases
present and other signal modulators within each brain region. Chronic binge ethanol models
of dependence also cause neurodegeneration depending upon the region, including forebrain
olfactory areas, insular, perirhinal, piriform and entorhinal association cortical areas; and
hippocampal dentate gyrus (Crews et al., 2000; Crews et al., 2004; Obernier et al., 2002a). The
hippocampus is an important brain region for learning, memory and mood that is altered by
ethanol. Alcoholism results in cognitive deficits in spatial learning and memory, short term
and declarative memory, and impulsivity, that are consistent with hippocampal dysfunction
(Brandt et al., 1983; Parsons, 1993; Sullivan et al., 2000). Hippocampal neuropathology in
human alcoholics (Agartz et al., 1999; Bengochea and Gonzalo, 1990; Laakso et al., 2000;
Sullivan et al., 1995) is consistent with hippocampal cell loss and dentate gyrus
neurodegeneration found in animal models of chronic alcohol consumption (Collins et al.,
1996; Obernier et al., 2002b; Walker et al., 1980). The dentate gyrus region of the hippocampus
contains resident neural progenitor cells that proliferate and differentiate into new neurons
throughout life. The inhibition of neurogenesis by chronic alcohol may contribute to
neurodegeneration via lack of cell generation (Nixon and Crews, 2002). Because p-CREB
contributes to both pro-survival signals in the promotion of cell survival and neurogenesis, it
may play a key role in neuronal plasticity. Alcohol alters neuronal plasticity via impacting cell
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survival and cell birth. Thus, alterations in p-CREB associated gene transcription, as a mediator
of these plasticity mechanisms affected in chronic ethanol exposure, could contribute to brain
changes associated with chronic alcoholism.
Indeed, p-CREB immunoreactivity in hippocampal dentate gyrus is reduced during ethanol
dependence (Bison and Crews, 2003). In addition, hippocampal neurogenesis is markedly
decreased during binge ethanol exposure (Nixon and Crews, 2002). Ethanol self-administration
decreases neural progenitor cell proliferation in a variety of brain regions (Crews et al.,
2004), likely due to increased progenitor cell death and reduced differentiation of progenitors
(He et al., 2005). Ethanol induced decreases in hippocampal p-CREB likely contribute to
ethanol inhibition of hippocampal neurogenesis and increased neurodegeneration.
Although hippocampal p-CREB appears to be reduced during chronic ethanol administration,
72 hrs of alcohol withdrawal result in increased p-CREB immunohistochemistry in the
hippocampal dentate gyrus (Bison and Crews, 2003). Withdrawal from ethanol also is
associated with an increase in progenitor cell proliferation and neurogenesis in hippocampus
(Nixon and Crews, 2004). Improvements in learning and memory are associated with increased
neurogenesis (van Praag et al., 1999) and increased p-CREB (Nagakura et al., 2002; Zhang et
al., 2000). Abstinence from alcohol in humans is associated with a reversal of hippocampal
neurodegeneration and a partial return of cognitive abilities (Carlen et al., 1978; Harper,
1998). p-CREB is associated with the recovery of hippocampal volume during recovery from
depression (Duman et al., 2001) and could contribute to improvements in mood associated
with recovery from alcoholism. A withdrawal-abstinence induced increase in pCREB in
hippocampus would be expected to contribute to the increased neurogenesis through increased
proliferation, reduced cell death and enhanced differentiation (Fig. 1).
In summary, p-CREB appears to contribute to brain vitality by inducing pro-survival genes
that prevent neuronal death and by stimulating neural progenitor cells to form new neurons.
Chronic ethanol administration causes neurodegeneration, inhibits neurogenesis and reduces
p-CREB in hippocampal dentate gyrus, whereas abstinence results in increases in neurogenesis,
loss of degeneration and increased hippocampal p-CREB. It is possible that pCREB represents
a key component of the long-term effects of chronic alcohol on brain as well as the changes
associated with recovery from alcohol dependence.
SEROTONIN DYSFUNCTION AND ALCOHOL PREFERENCE IN MICE
DEFICIENT IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF)
Julie G. Hensler
Disturbances of serotonergic neurotransmission in the brain have been implicated in the
pathogenesis and maintenance of alcoholism, as well as behavioral patterns relevant to alcohol
abuse. Both preclinical and clinical studies suggest an inverse relationship between central
serotonergic activity and alcoholism, impulse control disorders, aggression, negative mood
and low response to alcohol (LeMarquand et al., 1994a; Heinz et al., 2001). Decreased function
of central serotonergic systems is associated with increased alcohol preference and
consumption in rats. Depletion of serotonin in brain by inhibiting serotonin synthesis or by
using neurotoxins increases alcohol intake, impulsive behavior and aggression in laboratory
animals (LeMarquand et al., 1994b; Nelson and Chiavegatto, 2001). Pharmacological
interventions that increase serotonergic neurotransmission decrease alcohol consumption and
behavioral patterns relevant to alcoholism (LeMarquand et al., 1994a, b; Heinz et al., 2001;
Nelson and Chiavegatto, 2001).
BDNF promotes serotonergic neurotransmission by increasing serotonin synthesis and release,
and promotes the structural plasticity of serotonergic neurons in the adult brain. Thus, BDNF
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has an important role in the adult brain in maintaining the functional architecture of serotonergic
neurons (Mamounas et al., 2000). There is substantial evidence for reciprocal interactions
between BDNF and serotonin (Duman et al., 2002; MacQueen et al., 2003). Because, BDNF
promotes serotonergic neurotransmission and the functional architecture of serotonergic
neurons, it is tempting to speculate that deficiency in BDNF may cause abnormalities in
serotonin systems.
Heterozygous animals with one functional BDNF gene have forebrain BDNF mRNA and
protein levels that are 50% of that of wild-type mice and exhibit nonlethal abnormalities in
central serotonergic systems. In BDNF heterozygons (+/−) mice, the induction of c-Fos by the
specific serotonin releaser dexfenfluramine (an indication of neuronal activation in response
to serotonin) is blunted in many forebrain areas, including lateral frontal cortex, bed nucleus
of the stria terminalis, central nucleus of the amygdala and the shell region of the nucleus
accumbens (Lyons et al., 1999). These brain areas are key components of the forebrain
macrostructure “the extended amygdala,” the brain reward system implicated in the
development of alcoholism (Koob and LeMoal, 2001; Pandey, 2004). Consistent with these
deficits in serotonergic neurotransmission, BDNF heterozygons (+/−) mice exhibit enhanced
inter-male aggressiveness, which is reversed by chronic administration of the SSRI fluoxetine.
BDNF heterozygons (+/−) mice also develop premature age-associated decrements in forebrain
serotonin levels and fiber density (Lyons et al., 1999).
Dr. Hensler and her group have examined the alcohol drinking behavior in female BDNF
heterozygons (+/−) mice. BDNF heterozygons (+/−) mice display increased ethanol intake and
preference in the two-bottle choice procedure. There is no difference in the preference ratio
for nonalcoholic tastants (i.e., quinine or saccharin) between genotypes. Thus, the increased
ethanol consumption of BDNF heterozygons (+/−) versus wild-type mice appears not to reflect
a general difference in taste preference between genotypes, but may be related to the
pharmacological effects of ethanol, or perhaps an attenuation of the physiological or subjective
effects of alcohol in BDNF heterozygons (+/−) mice (Hensler et al., 2003).
The serotonin-1A (5-HT1A) receptor has been implicated in aggressive behavior and impulse
control disorders, as well as alcohol abuse. The 5-HT1A receptor, located on serotonergic cell
bodies in the brainstem, functions as the somatodendritic autoreceptor and therefore plays a
key role in regulating serotonergic neurotransmission. The 5-HT1A receptor is also located
postsynaptically to serotonergic neurons and is present in high density in cortical and limbic
structures. Dr. Hensler and her group have examined the function of 5-HT1A receptors at the
level of 5-HT1A receptor-G protein interaction in the brains of alcohol-naive BDNF
heterozygons (+/−) mice. The capacity of 5-HT1A receptors in cortical and limbic structures
to activate G proteins is decreased in BDNF heterozygons (+/−) mice, indicating that
postsynaptic 5-HT1A receptor function is diminished in many forebrain areas. Somatodendritic
5-HT1A receptor function at the level of receptor-G protein interaction is also reduced in BNDF
(±) mice. However, the total number of 5-HT1A receptor is not different between genotypes in
any area of brain examined (Hensler et al., 2003). Thus, attenuated 5–HT1A receptor function
may by a factor in alcohol abuse, as well as aggressive behavior in BDNF deficient mice.
A decrease in 5-HT1A autoreceptor function in the raphe nuclei would be expected to result in
a decrease in alcohol intake, given the well-established inverse relationship between
serotonergic neurotransmission and alcohol consumption discussed above. This is because
diminished 5–HT1A autoreceptor function would be expected to be associated with an increase
in serotonergic neurotransmission. However, the capacity of 5-HT1A receptors in cortical and
limbic structures to activate G proteins is decreased in BDNF heterozygons (+/−) mice,
indicating that postsynaptic 5-HT1A receptor function is diminished in forebrain areas.
Interestingly, these mice also show a blunted c-Fos induction by the specific serotonin releaser
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dexfenfluramine, a measure of neuronal activation in response to serotonin, in several forebrain
regions. Thus, serotonin neurotransmission appears to be attenuated in these animals.
In conclusion, a partial disruption in BDNF expression results in functional deficits in
serotonergic neurotransmission, and in serotonin-related behavioral abnormalities, i.e.,
heightened aggression and increased alcohol consumption and preference.
BDNF GENE AND RELATED SIGNALING: ROLE IN ANXIETY AND ALCOHOL
DEPENDENCE AND PREFERENCE
Subhash C. Pandey
The neurotrophin, BDNF, is a CREB target gene (Shieh et al., 1998; Pandey et al., 2004), which
plays a crucial role in synaptic plasticity in the brain (Schinder and Poo, 2000; Poo, 2001). Dr.
Pandey and his group reported earlier that CREB phosphorylation is decreased in the central
and medial but not in basolateral amygdala during ethanol withdrawal in rats treated chronically
with ethanol. The central nucleus of amygdala is an important brain region, which plays a role
in anxiety and motivational aspects of alcohol drinking (McBride, 2002; Koob 2003). They
reported that reduction in CREB phosphorylation in the central amygdala is involved in ethanol
withdrawal related anxiety in rats (Pandey et al., 2003). Interestingly, they also found that
CREB is causally involved in anxiolytic properties of ethanol and a deficiency in CREB
promotes higher alcohol drinking behaviors (Pandey et al., 2004). Recently it has been found
that the BDNF may be linked with vulnerability to alcohol abuse (Uhl et al., 2001; McGough
et al., 2004). Furthermore, ethanol exposure caused changes in BDNF levels in rat forebrain
areas (Pandey et al., 1999; Miller, 2004). The role of BDNF in anxiety is less clear. For example,
it has been shown that BDNF heterozygous mice do not show anxiety-like behaviors
(Montkowski and Holsboer, 1997). On the other hand, BDNF conditional knock out mice are
more prone to anxiety-like behaviors (Rios et al., 2001).
Dr. Pandey hypothesized that decreased BDNF signaling in amygdaloid structures may be
involved in anxiety and alcohol drinking behaviors (Pandey, 2003; 2004). They examined the
role of amygdaloid BDNF signaling in alcohol dependence and preference and also in anxiety-
like behaviors in rats. They found that chronic ethanol treatment had no effect on protein and
mRNA levels of BDNF as well as phosphorylation of extracellular-regulated protein kinases
(p-ERK1/2) in the various structures of amygdala. However, ethanol withdrawal (24 hrs after
15 days of ethanol exposure) produced significant reductions in the protein and mRNA levels
of BDNF as well as phosphorylation of ERK1/2 in the central, and medial but not in basolateral
amygdala. These results suggest the possibility that the decreased expression and function of
BDNF in the central and medial amygdala may be associated with the process of ethanol
dependence such as development of anxiety-like behaviors during withdrawal, and this may
be promoting the continued consumption of ethanol (Pandey, 2004). Several clinical and
preclinical studies suggest an association between anxiety and alcohol drinking behaviors
(Koob, 2003;Pandey, 2003; Cappell and Herman, 1972). Dr. Pandey and his group altered the
expression of BDNF in various amygdaloid structures using an antisense strategy and then
measured anxiety and alcohol drinking behaviors in normal rats. It was observed that BDNF
antisense oligodeoxynucleotides (ODNs) infusions into the central or medial but not into
basolateral amygdala provoked anxiety-like behaviors and also increased the alcohol
preference in rats, which was prevented by BDNF coinfusion. The mRNA and protein levels
of BDNF as well as protein levels of p-ERK1/2 and p-CREB were decreased by BDNF
antisense but not by sense ODNs infusions, which were restored to normal following BDNF
coinfusions. In support of this finding, they have also found that CREB-haplodeficient mice
have lower expression of BDNF in the brain and these mice are behaviorally anxious and have
higher preference to ethanol (Pandey et al., 2004). Taken together, these results indicate that
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decreased BDNF function in the central and medial amygdala may be involved in alcohol
preference and dependence and also in anxiety-like behaviors.
BDNF AND CREB: ROLE IN ETHANOL INDUCED NEURONAL DAMAGE
Wataru Ukai, and Toshikazu, Saito
Dr. Ukai and his group investigated the mechanisms of the disruption of neural network by the
treatment of ethanol on the process of neural network formation. In their previous study, they
demonstrated the ethanol-induced cortical neuronal survival change in the MTT metabolism
assay and LDH assay, and the contribution of transcriptional factor CREB reduction to their
function change (Sakai et al., 2004). Here, they investigated the effect of BDNF on ethanol-
induced neuronal damage. Cortical neurons were treated with 200 mM ethanol for 48 hr in the
presence or absence BDNF. Although exposure to ethanol significantly reduced neuronal
survival, the reduction was recovered significantly by the treatment of BDNF dose-
dependently. From these results they concluded that BDNF might play a protective role in
ethanol-induced reduction in neuronal survival. They next investigated the precise BDNF
production change by ethanol in the primary cortical neurons, and compared it to the alteration
of neuronal survival by ethanol. More than 200 mM ethanol can significantly affect neuronal
survival. However, a lower concentration of ethanol significantly decreased the amount of
BDNF secreted from the cortical neurons. These results suggest that the low concentration of
ethanol effects neuronal BDNF production, and induces a change in neuronal function that
may include alterations in synaptic formation, before the induction of neuronal survival
disruption.
Many investigators have indicated the function of BDNF in the regulation of neuronal survival
(Huang and Reichardt, 2001; Schinder and Poo, 2000). However, BDNF is known to regulate
the structure and function of synapses during development, and also regulate refinement of
neuronal connectivity in the adult brain (Gorski et al., 2003). So, they next analyzed the
neuronal developmental change by ethanol, focusing on the neuronal process formation in the
primary cortical neurons. They aimed to investigate whether low concentration of ethanol
effects neuronal process formation at a concentration that does not significantly change
neuronal cell survival. For the evaluation of process formation, they used immature primary
cortical neurons on 1DIV, and observed their morphological change for 48 hr. For the
evaluation of neuronal survival change, they used mature cortical neurons on 10 DIV, and
detected their morphology and viability change. The exposure to 100 mM ethanol for 48 hr
did not influence mature neuronal survival, and the same result obtained in the additional
neuronal viability assay of MTT. On the other hand, the suppression of neuronal process
formation was observed in the immature 3DIV neurons by exposure to 100 mM ethanol for 48
hr. Then, they investigated cellular signaling changes in regards to this neuronal function
change. In the process forming neurons, the BDNF-induced increase in phosphorylated Akt
was not changed by the co-treatment with MEK inhibitor (U0126) or 100 mM ethanol, in the
western blot analysis. On the other hand, the BDNF-increase in induced phosphorylated ERK
and phosphorylated CREB were reduced by the co-treatment with U0126 or ethanol. These
results indicate that the ERK/CREB signaling pathway plays an important role for the neuronal
function of process formation, and ethanol inhibits process formation through reduction of
ERK/CREB signaling in the process forming neurons. The other neurotrophic factor-signaling
molecule, Akt seemed to be less important in the function of process formation.
Alteration of the cAMP-signaling pathway, especially a BDNF production change by ethanol,
seems to induce neuronal cell damage. Ethanol inhibited neuronal process formation in the
lower concentration that has little effect on neuronal cell survival. This may be also related to
the reduction in BDNF production by ethanol exposure. The above results suggest that changes
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in ethanol-induced BDNF production may cause impairment of brain networks by both
reduction of survival and inhibition of neuronal process formation.
SUMMARY
The data presented in this symposium suggest the complex role of BDNF signaling in
behavioral and pathologic consequences of ethanol exposure. Data presented by Dr. Chandler
suggest that alcohol may enhance the BDNF expression via NMDA receptor linked activation
of ERK and CREB signaling without directly modulating the BDNF activation in cortical
neurons. Further data presented by Dr. Ukai provided evidence that BDNF is important in
ethanol-induced reduction in survival of cortical neurons. Dr. Crews presented data, which
suggests that CREB is crucial in the regulation of ethanol-induced neurogenesis in the
hippocampus. Dr. Hensler’s data provided evidence that BDNF regulates the function of 5-
HT1A receptors and decreased function of these receptors in BDNF deficient mice may be
involved in higher alcohol preference. The data presented by Dr. Pandey suggest that decreased
function of BDNF in the amygdala may be important in the anxiety-like and alcohol drinking
behaviors of rats. Taken together these data provided evidence to suggests that BDNF and
related signaling play an important role in pathophysiology of alcoholism.
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Neurogenesis and pCREB Immunohistochemistry in dentate gyrus of binge alcohol treated
rats. Rats were treated with a 4-day binge treatment that induces alcohol dependence, causes
dentate gyrus degeneration and reduced neurogenesis. The upper bar graph shows neurogenesis
at three time points relative to pair fed controls. Note that after four days of binge ethanol
treatment (T0), neurogenesis is decreased whereas during abstinence for 72 hrs (T72) or 168hrs
(T168) neurogenesis is progressively increased. Left panels: pCREB immunohistochemical
staining in control rats (upper left panel, pCREB Con) is greater than that found in rats after
four days of binge intoxication (middle left panel, pCREB E-TO). In rats abstinent from alcohol
for 72 hrs staining for pCREB is greatly increased (lower left, pCREB E-T72; Bison and Crews,
2003). Right panels: BrdU immunohistochemistry is used to assess proliferation of
neuroprogenetor cells. Adult controls have a modest number of cells stained (upper right, BrdU
Con), whereas after four days of binge treatment there are fewer cells (middle right, BrdU E-
T0). However, during abstinence for 196 hrs there is a tremendous increase in BrdU+IR cells
in the dentate gyrus (lower right, BrdU E-T168). Chronic treatment with rolipram to increase
pCREB can increase neurogenesis (Nakagawa et al., 2002). It is possible that there is a delay
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between the increase in pCREB and the time required to induce prosurvival and trophic factors
that contribute to the increased neurogenesis observed during ethanol abstinence (Nixon and
Crews, 2002; 2004).
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